These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 18617486)

  • 1. Role of co-trimoxazole prophylaxis in reducing mortality in HIV infected adults being treated for tuberculosis: randomised clinical trial.
    Nunn AJ; Mwaba P; Chintu C; Mwinga A; Darbyshire JH; Zumla A;
    BMJ; 2008 Jul; 337():a257. PubMed ID: 18617486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of trimethoprim-sulphamethoxazole prophylaxis to decrease morbidity and mortality in HIV-1-infected patients with tuberculosis in Abidjan, Côte d'Ivoire: a randomised controlled trial.
    Wiktor SZ; Sassan-Morokro M; Grant AD; Abouya L; Karon JM; Maurice C; Djomand G; Ackah A; Domoua K; Kadio A; Yapi A; Combe P; Tossou O; Roels TH; Lackritz EM; Coulibaly D; De Cock KM; Coulibaly IM; Greenberg AE
    Lancet; 1999 May; 353(9163):1469-75. PubMed ID: 10232312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Daily co-trimoxazole prophylaxis in severely immunosuppressed HIV-infected adults in Africa started on combination antiretroviral therapy: an observational analysis of the DART cohort.
    Walker AS; Ford D; Gilks CF; Munderi P; Ssali F; Reid A; Katabira E; Grosskurth H; Mugyenyi P; Hakim J; Darbyshire JH; Gibb DM; Babiker AG
    Lancet; 2010 Apr; 375(9722):1278-86. PubMed ID: 20347483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Daily co-trimoxazole prophylaxis to prevent mortality in children with complicated severe acute malnutrition: a multicentre, double-blind, randomised placebo-controlled trial.
    Berkley JA; Ngari M; Thitiri J; Mwalekwa L; Timbwa M; Hamid F; Ali R; Shangala J; Mturi N; Jones KD; Alphan H; Mutai B; Bandika V; Hemed T; Awuondo K; Morpeth S; Kariuki S; Fegan G
    Lancet Glob Health; 2016 Jul; 4(7):e464-73. PubMed ID: 27265353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early chemoprophylaxis with trimethoprim-sulphamethoxazole for HIV-1-infected adults in Abidjan, Côte d'Ivoire: a randomised trial. Cotrimo-CI Study Group.
    Anglaret X; Chêne G; Attia A; Toure S; Lafont S; Combe P; Manlan K; N'Dri-Yoman T; Salamon R
    Lancet; 1999 May; 353(9163):1463-8. PubMed ID: 10232311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-trimoxazole as prophylaxis against opportunistic infections in HIV-infected Zambian children (CHAP): a double-blind randomised placebo-controlled trial.
    Chintu C; Bhat GJ; Walker AS; Mulenga V; Sinyinza F; Lishimpi K; Farrelly L; Kaganson N; Zumla A; Gillespie SH; Nunn AJ; Gibb DM;
    Lancet; 2004 Nov 20-26; 364(9448):1865-71. PubMed ID: 15555666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of co-trimoxazole on mortality in HIV-exposed but uninfected children in Botswana (the Mpepu Study): a double-blind, randomised, placebo-controlled trial.
    Lockman S; Hughes M; Powis K; Ajibola G; Bennett K; Moyo S; van Widenfelt E; Leidner J; McIntosh K; Mazhani L; Makhema J; Essex M; Shapiro R
    Lancet Glob Health; 2017 May; 5(5):e491-e500. PubMed ID: 28395844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized trial of prolonged co-trimoxazole in HIV-infected children in Africa.
    Bwakura-Dangarembizi M; Kendall L; Bakeera-Kitaka S; Nahirya-Ntege P; Keishanyu R; Nathoo K; Spyer MJ; Kekitiinwa A; Lutaakome J; Mhute T; Kasirye P; Munderi P; Musiime V; Gibb DM; Walker AS; Prendergast AJ
    N Engl J Med; 2014 Jan; 370(1):41-53. PubMed ID: 24382064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Level of understanding of co-trimoxazole use among HIV infected, recurrent pulmonary tuberculosis suspects at a national referral tuberculosis clinic in Kampala, Uganda: a qualitative analysis.
    Okwera A; Mafigiri DK; Guwatudde D; Whalen C; Joloba M
    Afr Health Sci; 2015 Mar; 15(1):49-57. PubMed ID: 25834530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Co-trimoxazole (Trimethoprim-Sulfamethoxazole) vs Placebo on Death, Lung Transplant, or Hospital Admission in Patients With Moderate and Severe Idiopathic Pulmonary Fibrosis: The EME-TIPAC Randomized Clinical Trial.
    Wilson AM; Clark AB; Cahn T; Chilvers ER; Fraser W; Hammond M; Livermore DM; Maher TM; Parfrey H; Swart AM; Stirling S; Thickett DR; Whyte M;
    JAMA; 2020 Dec; 324(22):2282-2291. PubMed ID: 33289822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-trimoxazole prophylaxis in adults, including pregnant women, with HIV: a systematic review and meta-analysis.
    Suthar AB; Vitoria MA; Nagata JM; Anglaret X; Mbori-Ngacha D; Sued O; Kaplan JE; Doherty MC
    Lancet HIV; 2015 Apr; 2(4):e137-50. PubMed ID: 26424674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of co-trimoxazole prophylaxis on morbidity, mortality, CD4-cell count, and viral load in HIV infection in rural Uganda.
    Mermin J; Lule J; Ekwaru JP; Malamba S; Downing R; Ransom R; Kaharuza F; Culver D; Kizito F; Bunnell R; Kigozi A; Nakanjako D; Wafula W; Quick R
    Lancet; 2004 Oct 16-22; 364(9443):1428-34. PubMed ID: 15488218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of vitamin D
    Sudfeld CR; Mugusi F; Muhihi A; Aboud S; Nagu TJ; Ulenga N; Hong B; Wang M; Fawzi WW
    Lancet HIV; 2020 Jul; 7(7):e463-e471. PubMed ID: 32621874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of daily cotrimoxazole prophylaxis and antiretroviral therapy on mortality and hospital admissions in HIV-infected Zambian children.
    Walker AS; Mulenga V; Ford D; Kabamba D; Sinyinza F; Kankasa C; Chintu C; Gibb DM;
    Clin Infect Dis; 2007 May; 44(10):1361-7. PubMed ID: 17443476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of tuberculosis preventive therapy on tuberculosis and mortality in HIV-infected children.
    Gray DM; Zar H; Cotton M
    Cochrane Database Syst Rev; 2009 Jan; (1):CD006418. PubMed ID: 19160285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tuberculosis incidence is high in HIV-infected African children but is reduced by co-trimoxazole and time on antiretroviral therapy.
    Crook AM; Turkova A; Musiime V; Bwakura-Dangarembizi M; Bakeera-Kitaka S; Nahirya-Ntege P; Thomason M; Mugyenyi P; Musoke P; Kekitiinwa A; Munderi P; Nathoo K; Prendergast AJ; Walker AS; Gibb DM;
    BMC Med; 2016 Mar; 14():50. PubMed ID: 27004529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective efficacy of prolonged co-trimoxazole prophylaxis in HIV-exposed children up to age 4 years for the prevention of malaria in Uganda: a randomised controlled open-label trial.
    Homsy J; Dorsey G; Arinaitwe E; Wanzira H; Kakuru A; Bigira V; Muhindo M; Kamya MR; Sandison TG; Tappero JW
    Lancet Glob Health; 2014 Dec; 2(12):e727-36. PubMed ID: 25433628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylaxis with co-trimoxazole for HIV infected adults in Africa.
    Anglaret X; Eholie S
    BMJ; 2008 Jul; 337():a304. PubMed ID: 18614521
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of isoniazid prophylaxis on mortality and incidence of tuberculosis in children with HIV: randomised controlled trial.
    Zar HJ; Cotton MF; Strauss S; Karpakis J; Hussey G; Schaaf HS; Rabie H; Lombard CJ
    BMJ; 2007 Jan; 334(7585):136. PubMed ID: 17085459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of co-trimoxazole prophylaxis on morbidity and mortality of HIV-exposed, HIV-uninfected infants in South Africa: a randomised controlled, non-inferiority trial.
    Daniels B; Coutsoudis A; Moodley-Govender E; Mulol H; Spooner E; Kiepiela P; Reddy S; Zako L; Ho NT; Kuhn L; Ramjee G
    Lancet Glob Health; 2019 Dec; 7(12):e1717-e1727. PubMed ID: 31708152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.